Join Christian Kramme, Chief Scientific Officer at Gameto, and Derk Arts, CEO of Castor, for a behind-the-scenes look at how a small team launched a global clinical program and reached Phase 3—fast.
What does it take to bring a first-in-class cell therapy from exploratory studies to a Phase 3 trial in the U.S.—efficiently, compliantly, and without unnecessary complexity?
In this live webinar, Christian and Derk will walk through the clinical journey behind Gameto’s fertility treatment platform. You’ll hear how the team ran nine global studies with a small, high-performing team—turning early data into FDA-cleared evidence for their pivotal trial.
They’ll explore:
- What it takes to run fast, high-integrity studies across geographies
- How early clinical data shaped regulatory strategy and trial design
- Why staying close to your data (and your sites) makes a difference
- How Castor supported Gameto’s journey as an enabling platform partner
From study builds to monitoring workflows, Castor helped power Gameto’s clinical strategy—proving that the right tools and partnerships can unlock outsized impact.
Whether you’re leading clinical ops, digital health, or translational science, this conversation will offer practical insights for scaling research with speed and precision.
📍 Zoom Webinar | 30-minute session + live Q&A
Register now to save your spot.
